Status: Recruiting
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
This is a study that will enroll patients with cancer who have tumors that may have spread. The patients will know what medication they are being given. There will be 2 parts to the study. For the first part of the study only one medication will be taken, and the dose changed to a higher dose over time. In the second part of the study tow medications will be taken and the dose of the medication may be changed to a higher dose.
Participants needed: 57
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lei ZhengUpdated: Jun 3, 2026Locations: 1
Eligibility criteria
Read, understood, and provided written informed consent and must be willing to c... [+16]
Known allergies, hypersensitivity, or intolerance to monoclonal antibodies (mAbs... [+21]